Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 8.12
Day High 8.43
Open:8.28
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Top 1000
Aphria Inc. is ranked 394 out of The Top 1000, Report on Business magazine’s exclusive ranking of Canada’s largest companies.
Description
Aphria Inc and its subsidiaries produce and sell medical marijuana. Its products include Capsules, Oral solutions, and Vaporizers. The company's operations are based in Leamington, Ontario. It is focused on producing and selling medical marijuana and its derivatives through retail sales and wholesale channels. It operates through following segments: Cannabis operations which encompasses the production, distribution and sale of both medical and adult-use cannabis, Distribution operations and Businesses under development segment.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

The Top Companies Disrupting a Massive $23.7 Billion Medical Cannabis Market
- PR Newswire - Tue Sep 17, 7:50AM CDT
PR Newswire - CMTX
Tue Sep 17, 7:50AM CDT
Global demand for cannabis-based consumer products has been increasing at a rapid pace. In fact, the Brightfield Group estimates the U.S. CBD product market alone to be worth over $23.7 billion by 2023, as CBD finds its way into a variety of consumer product categories including food and beverage, pharmaceuticals, and health and wellness. Analysts at Research and Markets say the global medical cannabis market could be worth up to $44.4 billion by 2024 from just $13.4 billion last year. In addition, analysts at Statista says U.S. medical retail sales could reach $7.3 billion by 2022, as compared to $4.5 billion sales in 2018. Better, according to a May 2018 survey from Nielsen, analysts found that consumers are quickly embracing CBD products, particularly when it comes to medicinal purposes. In fact, according to the survey, 40% of head and migraine suffers are considering cannabis in addition to 40% of all arthritis pain suffers, and 41% of all back and neck pain sufferers. As CBD continues to disrupt major industries, it's creating a wide range of opportunity for companies such as XPhyto Therapeutics Corp. (CSE:XPHY), HEXO Corporation (NYSE:HEXO)(TSX:HEXO), Aphria Inc. (NYSE:APHA) (TSX:APHA), Tilray Inc. (NASDAQ:TLRY), and OrganiGram Holdings Inc. (TSX-V:OGI)(NASDAQ:OGI).
These Are Some of the Top Beneficiaries of Canada's October 2019 CBD News
- PR Newswire - Fri Sep 13, 8:50AM CDT
PR Newswire - PRNW
Fri Sep 13, 8:50AM CDT
PALM BEACH, Florida , Sept. 13, 2019 /PRNewswire/ -- This October, CBD will retake center stage.  In fact, on October 17, 2019 , Canada is expected to legalize it for the second time.  A year after Canada legalized dried cannabis flower, oils, and sprays, the country is expected to legalize edibles, beverages, and topicals, including cannabis vapes, which, by the way, were not included on President Trump's list of potential bans. In addition, Health Canada even recommended vaping over smoking.  Plus, according to analysts at Deloitte, up to 60% of Canadians would use cannabis edible products.  That's opening a wide range of opportunity for companies such as Nutritional High International Inc. (CSE:EAT) (OTCQB:SPLIF), KushCo Holdings Inc. (OTCQX:KSHB), Cronos Group Inc. (NASDAQ:CRON), Aphria Inc.  (NYSE:APHA) (TSX:APHA), and Altria Group Inc. (NYSE:MO).
These Are Some of the Top Beneficiaries of Canada's October 2019 CBD News
- PR Newswire - Fri Sep 13, 8:50AM CDT
PR Newswire - CMTX
Fri Sep 13, 8:50AM CDT
This October, CBD will retake center stage. In fact, on October 17, 2019, Canada is expected to legalize it for the second time. A year after Canada legalized dried cannabis flower, oils, and sprays, the country is expected to legalize edibles, beverages, and topicals, including cannabis vapes, which, by the way, were not included on President Trump's list of potential bans. In addition, Health Canada even recommended vaping over smoking. Plus, according to analysts at Deloitte, up to 60% of Canadians would use cannabis edible products. That's opening a wide range of opportunity for companies such as Nutritional High International Inc. (CSE:EAT) (OTCQB:SPLIF), KushCo Holdings Inc. (OTCQX:KSHB), Cronos Group Inc. (NASDAQ:CRON), Aphria Inc. (NYSE:APHA) (TSX:APHA), and Altria Group Inc. (NYSE:MO).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 7.70 +8.57% increase
on 08/28/19
Period Open:8.17
Price movement based on the high, low and last over the given period.
9.38 -10.87% decrease
on 09/09/19
+0.19 (+2.33%) increase
since 08/16/19
3-Month 6.64 +25.90% increase
on 08/01/19
Period Open:9.13
Price movement based on the high, low and last over the given period.
10.05 -16.82% decrease
on 08/06/19
-0.77 (-8.43%) decrease
since 06/18/19
52-Week 4.76 +75.63% increase
on 12/05/18
Period Open:20.80
Price movement based on the high, low and last over the given period.
21.58 -61.26% decrease
on 09/19/18
-12.44 (-59.81%) decrease
since 09/18/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).